YOLFTbeta
BioPharma Credit PLC

BioPharma Credit PLC

BPCR · LSE · Financial Services / Asset Management

0.986USD-0.00 (-0.40%)

Price History

Full chart

Market Stats

Previous Close0.99
Open0.992
Day Range0.98 – 0.994
52-Week Range0.8161 – 1.00
Volume573.96K
Market Cap1.10B
P/E (TTM)0.10
Forward P/E0.00
EPS0.11
Dividend Yield7.25%
Beta0.18
50-Day Avg0.9718
200-Day Avg0.9481

About

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEOMr. Pedro Gonzalez de Cosio
  • Employees0
  • Headquarters51 Lime Street, London, United Kingdom, EC3M 7DQ, UK
  • Websitehttps://www.bpcruk.com

Leadership

  • Mr. Pedro Gonzalez de CosioInvestment Manager
  • Mr. Pablo LegorretaInvestment Manager · b. 1963
  • Mr. Martin FriedmanInvestment Manager · b. 1965

Financials

Income Statement

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue33.65M78.72M124.12M91.35M87.97M184.25M159.68M124.46M140.23M
Growth (%)-+133.95%+57.67%-26.40%-3.70%+109.44%-13.33%-22.06%+12.67%
Cost of Revenue5.83M18.56M27.59M18.65M15.89M33.90M25.24M25.57M25.73M
Gross Profit33.65M60.16M124.12M91.35M87.97M184.25M110.49M124.46M114.50M
Gross Margin100.00%76.42%100.00%100.00%100.00%100.00%69.19%100.00%81.65%
Operating Expense6.53M-9.99M1.79M2.22M3.01M1.93M2.04M2.28M-15.35M
Operating Income27.12M70.15M122.33M89.14M84.96M182.31M108.45M122.18M129.85M
Operating Margin80.61%89.11%98.56%97.57%96.58%98.95%67.92%98.17%92.60%
EBITDA27.12M74.08M122.33M89.14M84.96M182.31M108.46M122.18M129.89M
EBITDA Margin80.61%94.11%98.56%97.57%96.58%98.95%67.92%98.17%92.62%
Net Income27.16M70.15M122.33M89.14M84.96M182.31M108.45M122.18M129.89M
Net Income Margin80.73%89.11%98.56%97.57%96.58%98.95%67.92%98.17%92.62%
Interest Expense03.00K000----
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%----

Balance Sheet

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets925.49M1.39B1.43B1.39B1.37B1.36B1.36B1.20B1.17B
Total Liabilities2.92M13.25M25.23M9.39M6.90M26.30M15.87M17.94M17.56M
Total Equity922.57M1.38B1.40B1.38B1.36B1.34B1.34B1.18B1.15B
Cash350.82M363.57M296.64M193.27M94.71M120.53M86.20M5.62M12.59M
Net Debt-350.82M-363.57M-296.64M-193.27M-94.71M-120.53M-86.20M-5.62M-12.59M

Cash Flow

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.07M67.14M131.52M58.07M96.44M184.28M123.18M111.91M91.09M
Investing Cash Flow-354.74M-436.99M-100.30M-47.47M-94.82M48.19M-1.66M39.07M77.48M
Financing Cash Flow632.34M382.64M-98.15M-113.96M-100.16M-206.62M-106.99M-280.42M-161.65M
Capital Expenditure000000000
Free Cash Flow23.07M67.14M131.52M58.07M96.44M184.28M123.18M111.91M91.09M
Dividends Paid6.53M74.04M98.61M113.90M100.16M156.54M89.77M174.66M110.38M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF28.31%110.28%74.98%196.13%103.86%84.95%72.88%156.07%121.17%

Earnings

Report DateSep 21, 2017Mar 8, 2018Sep 27, 2018Mar 5, 2019Sep 4, 2019Mar 10, 2020Aug 31, 2020Mar 8, 2021Sep 15, 2021Mar 22, 2022Sep 14, 2022Mar 22, 2023Mar 25, 2025Sep 19, 2025
EPS Estimate0.000.000.000.000.000.000.000.00----0.000.00
EPS Actual0.010.030.040.030.060.030.030.040.030.030.050.080.040.06
Surprise--------------
TimingAfter-hoursAfter-hoursAfter-hours------Pre-marketPre-marketPre-market--

Key Statistics & Ratios

Market Cap1.10B
Enterprise Value1.08B
Trailing P/E0.10
Forward P/E0.00
Price / Sales8.37
Price / Book0.95
EPS0.11
Book Value1.02
Revenue (TTM)157.75M
Gross Profit (TTM)157.75M
Profit Margin82.34%
Operating Margin77.19%
Return on Equity11.14%
Return on Assets6.85%
Shares Outstanding1.12B
Shares Float1.13B
Beta0.18
Dividend Yield7.25%
Dividend Rate0.07
Payout Ratio0.00%

Dividends

20263×
0.02Jul 2, 20260.02Apr 30, 20260.03Feb 19, 2026
20254×
0.03Sep 25, 20250.02Jun 26, 20250.02Apr 3, 20250.03Jan 30, 2025
20244×
0.04Sep 26, 20240.02Jul 4, 20240.02Mar 28, 20240.03Feb 15, 2024
20234×
0.04Dec 7, 20230.02Aug 17, 20230.02Apr 27, 20230.03Mar 30, 2023
20224×
0.06Oct 20, 20220.02Aug 25, 20220.02May 5, 20220.02Mar 3, 2022
20214×
0.02Nov 18, 20210.02Aug 19, 20210.02Jun 3, 20210.02Mar 18, 2021
20201×
0.02Nov 19, 2020